Atlas Trials

Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients

Clinical trial NCT00910273 · TERMINATED

Trial details

NCT number
NCT00910273
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Ankylosing Spondylitis
Start date
2009-07-01
Primary completion
2011-10-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.